Unlocking Antidepressant Efficacy with Pharmacogenomics
Discover how pharmacogenomic differences, especially in the CYP2D6 enzyme, explain varied antidepressant responses. Learn how genetic insights can personalize treatment, reducing trial-and-error and improving patient outcomes.
